#ExistRefRangeSet>
Reference Interval:
#ExistRefRange>29 AU/mL or less: Negative 30-40 AU/mL: Equivocal 41 AU/mL or greater: Positive
*ExistRefRange>
|
*ExistRefRangeSet>
#ExistInterpDataSet>
| Interpretive Data: |
#ExistInterpData>Scleroderma (Scl-70) antibody is seen in 20-60% of patients with scleroderma and is considered diagnostic and specific for scleroderma if it is the only ENA antibody present. Scl-70 is also seen in approximately 25% of progressive systemic sclerosis (PSS).
*ExistInterpData>
|
*ExistInterpDataSet>
#ExistCPT>
| CPT Code(s): |
86235
|
*ExistCPT>
#ExistCrossReferences>
Cross References: |
Anti-Scleroderma (Scl-70) (ENA) Antibody (Scleroderma (Scl-70) (ENA) Antibody, IgG), Topo 1 (Scleroderma (Scl-70) (ENA) Antibody, IgG), Topoisomerase 1 Antibody (Scleroderma (Scl-70) (ENA) Antibody, IgG), Topoisomerase I Antibody (Scleroderma (Scl-70) (ENA) Antibody, IgG) |
*ExistCrossReferences>